118 related articles for article (PubMed ID: 2879412)
1. Further studies of the mechanism behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in rats.
Arnt J; Hyttel J; Bach-Lauritsen T
Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):319-24. PubMed ID: 2879412
[TBL] [Abstract][Full Text] [Related]
2. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
3. Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics.
Arnt J; Christensen AV
Eur J Pharmacol; 1981 Jan; 69(1):107-11. PubMed ID: 6110555
[TBL] [Abstract][Full Text] [Related]
4. The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.
Arnt J; Hyttel J; Larsen JJ
Acta Pharmacol Toxicol (Copenh); 1984 Nov; 55(5):363-72. PubMed ID: 6152104
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.
Christensen AV; Arnt J; Hyttel J; Larsen JJ; Svendsen O
Life Sci; 1984 Apr; 34(16):1529-40. PubMed ID: 6144029
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade.
Arnt J
Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):321-9. PubMed ID: 6129770
[TBL] [Abstract][Full Text] [Related]
7. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
Christensen AV; Arnt J; Hyttel J; Svendsen O
Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
[TBL] [Abstract][Full Text] [Related]
8. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
Butkerait P; Friedman E
Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological differentiation of dopamine D-1 and D-2 antagonists after single and repeated administration.
Christensen AV; Arnt J; Svendsen O
Psychopharmacology Suppl; 1985; 2():182-90. PubMed ID: 2860659
[TBL] [Abstract][Full Text] [Related]
10. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.
Arnt J
Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):97-104. PubMed ID: 2864641
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats.
Wanibuchi F; Usuda S
Psychopharmacology (Berl); 1990; 102(3):339-42. PubMed ID: 1979179
[TBL] [Abstract][Full Text] [Related]
12. Catalepsy induced by SCH 23390 in rats.
Morelli M; Di Chiara G
Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
Arnt J
Eur J Pharmacol; 1983 May; 90(1):47-55. PubMed ID: 6135618
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity.
Ondrusek MG; Kilts CD; Frye GD; Mailman RB; Mueller RA; Breese GR
Psychopharmacology (Berl); 1981; 73(1):17-22. PubMed ID: 6112768
[TBL] [Abstract][Full Text] [Related]
15. SCH 23390--a selective dopamine D-1 receptor antagonist with putative 5-HT1 receptor agonistic activity.
Skarsfeldt T; Larsen JJ
Eur J Pharmacol; 1988 Apr; 148(3):389-95. PubMed ID: 2968272
[TBL] [Abstract][Full Text] [Related]
16. Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potential.
Arnt J; Christensen AV; Hyttel J
Neuropharmacology; 1981 Dec; 20(12B):1331-4. PubMed ID: 6119645
[No Abstract] [Full Text] [Related]
17. Cholinergic maturation and SCH 23390-induced catalepsy in the male rat pup.
Fitzgerald LW; Hannigan JH
Brain Res Dev Brain Res; 1989 May; 47(1):147-50. PubMed ID: 2525433
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
Arnt J; Hyttel J
Eur J Pharmacol; 1984 Jul; 102(2):349-54. PubMed ID: 6148252
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions.
Hirose A; Kato T; Ohno Y; Shimizu H; Tanaka H; Nakamura M; Katsube J
Jpn J Pharmacol; 1990 Jul; 53(3):321-9. PubMed ID: 1975278
[TBL] [Abstract][Full Text] [Related]
20. Effects of dopamine D-1 and D-2 antagonists on decision making by rats: no reversal of neuroleptic-induced attenuation by scopolamine.
Ljungberg T; Enquist M
J Neural Transm Gen Sect; 1990; 82(3):167-79. PubMed ID: 1979001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
